×
About 1,993 results

ALLMedicine™ Allergic Conjunctivitis Center

Research & Reviews  307 results

Severity and duration of allergic conjunctivitis: are they associated with severity and...
https://doi.org/10.23822/EurAnnACI.1764-1489.231
European Annals of Allergy and Clinical Immunology; Sánchez-Hernández MC, Dordal MT et. al.

Jul 28th, 2021 - Objective. The association of allergic conjunctivitis (AC) with rhinitis and/or asthma is poorly understood. The objective of this study was to apply the Consensus Document for Allergic Conjunctivitis (DECA) criteria for the classification of AC t...

Four subtypes of childhood allergic rhinitis identified by latent class analysis.
https://doi.org/10.1111/pai.13605
Pediatric Allergy and Immunology : Official Publication O... Yavuz ST, Oksel Karakus C et. al.

Jul 27th, 2021 - Childhood allergic rhinitis (AR) is clinically heterogeneous. We aimed to identify distinct phenotypes amongst children with AR using data-driven techniques, and to ascertain their association with patterns of symptoms, allergic sensitization and ...

Prevalence and factors associated with ocular morbidity among prisoners of Luzira priso...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278745
BMC Ophthalmology; Zalwango C, Ayebare P et. al.

Jul 16th, 2021 - Globally, ocular morbidity has emerged as a major public concern with at least 2.2 billion people having vision impairment or blindness. Prisoners (inmates) tend to have limited access to health care especially eye health, and as a result some con...

Correction: Non-cell-autonomous OTX2 transcription factor regulates anxiety-related beh...
https://doi.org/10.1038/s41380-021-01195-x
Molecular Psychiatry; Vincent C, Gilabert-Juan J et. al.

Jun 27th, 2021 - This large cross-sectional population-based study investigated the relationship between dry eye disease (DED) and health-related quality of life (HR-QoL). Dry eye and HR-QoL were assessed in 78,165 participants (19-94 yrs, 59.2% female) from the D...

Drawing Attention to the Burden of Allergic Conjunctivitis in Children and Their Families.
https://doi.org/10.1001/jamaophthalmol.2021.1714
JAMA Ophthalmology; Strube YNJ

Jun 11th, 2021 - Drawing Attention to the Burden of Allergic Conjunctivitis in Children and Their Families.|2021|Strube YNJ,|

see more →

Drugs  411 results see all →

Clinicaltrials.gov  48 results

The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer
https://clinicaltrials.gov/ct2/show/NCT01346371

Mar 31st, 2020 - This is a single-center, randomized, parallel group, placebo-controlled study to evaluate the effect of BEPREVE compared to a placebo eye drop on the measurement of tear film osmolarity and tear film lipid layer in patients with allergic conjuncti...

Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT03368339

Jan 29th, 2020 - A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of PR013 Topical Ophthalmic Drops (0.045% and 0.06%) Compared to Vehicle of PR013 Topical Ophthalmic Drops for the Treatment of Allergic Conjunctivitis Using a Modi...

A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT03660878

Dec 20th, 2019 - A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled, Methodology Development Environmental Clinical Trial with Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis.

A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT03379311

Aug 29th, 2019 - This is a Phase 1b, open-label, study to assess the effects of AK002, given as monthly intravenous infusion for 6 doses at up to 3 mg/kg.

A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
https://clinicaltrials.gov/ct2/show/NCT03709121

Jul 11th, 2019 - An Exploratory Clinical Trial Evaluating Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber (EEC)

see more →

News  29 results

Allergic Conjunctivitis Severely Affects Children's Quality of Life
https://www.medscape.com/viewarticle/953091

Jun 15th, 2021 - Allergic conjunctivitis harms quality of life for children and their parents, apparently causing greater day-to-day worries than potentially blinding diseases, researchers report. Parents worry especially that treatments might not be effective, ac...

Eton's conjunctivitis treatment fails to win FDA nod; shares tumble
https://www.reuters.com/article/us-eton-pharms-fda/etons-conjunctivitis-treatment-fails-to-win-fda-nod-shares-tumble-idUSKCN1U72KP

Jul 12th, 2019 - (Reuters) - Eton Pharmaceuticals Inc said on Friday that the U.S. Food and Drug Administration declined to approve its treatment for conjunctivitis, sending its shares tumbling nearly 20 percent in extended trading. No concerns were raised about t...

5 Myths About Dry Eye Disease
https://www.staging.medscape.com/viewarticle/911753_1

Apr 17th, 2019 - Dry eyes should not be dismissed as a minor inconvenience and something quickly remedied with over-the-counter eye drops. Dry eye disease is actually an impressively complex condition that significantly affects patients' quality of life. In fact, ...

PPIs, H2RAs in infants raise later allergy risk
https://www.mdedge.com/familymedicine/article/162389/neonatal-medicine/ppis-h2ras-infants-raise-later-allergy-risk/page/0/1
Pediatric News;

Apr 2nd, 2018 - The use of antibiotics in the first 6 months of life was associated with a 14% higher incidence of food allergy but with a 24% higher risk of cow’s milk allergy and egg allergy. Children prescribed antibiotics also had a twofold greater risk of as.

Tx for Allergic Conjunctivitis Falls Short: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/68445

Oct 10th, 2017 - A recent meta-analysis evaluated the risk of intraocular bleeding with newer anticoagulant medications compared with warfarin. A new survey suggests that current therapies to treat allergic conjunctivitis are inadequate. The European Commission re...

see more →

Patient Education  2 results see all →